StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)

Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –

Integra LifeSciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Integra LifeSciences's profit margin for the twelve months ending Sep 30, 2026 was 0.8%. For fiscal 2025 it was -31.6%, against -0.4% the year before. The highest annual figure on record is 11.6% in fiscal 2022.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-31.6%−31.2
FY2024Dec 31, 2024-0.4%−4.8
FY2023Dec 31, 20234.4%−7.2
FY2022Dec 31, 202211.6%+0.6
FY2021Dec 31, 202111.0%+1.2
FY2020Dec 31, 20209.8%+6.5
FY2019Dec 31, 20193.3%−0.8
FY2018Dec 31, 20184.1%−1.3
FY2017Dec 31, 20175.4%−2.1
FY2016Dec 31, 20167.5%+7.9
FY2015Dec 31, 2015-0.4%−4.7
FY2014Dec 31, 20144.3%+7.3
FY2013Dec 31, 2013-3.0%−8.0
FY2012Dec 31, 20125.0%+1.4
FY2011Dec 31, 20113.6%−5.4
FY2010Dec 31, 20109.0%+1.5
FY2009Dec 31, 20097.5%+3.2
FY2008Dec 31, 20084.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 20263.6%+5.0
Q2 FY2026Jun 30, 20261.1%+117.5
Q1 FY2026Mar 31, 2026-1.2%+5.4
Q4 FY2025Dec 31, 2025-0.4%−4.8
Q3 FY2025Sep 30, 2025-1.3%+1.5
Q2 FY2025Jun 30, 2025-116.5%−113.5
Q1 FY2025Mar 31, 2025-6.6%−5.7
Q4 FY2024Dec 31, 20244.4%−0.6
Q3 FY2024Sep 30, 2024-2.8%−7.9
Q2 FY2024Jun 30, 2024-3.0%−4.1
Q1 FY2024Mar 31, 2024-0.9%−7.3
Q4 FY2023Dec 31, 20235.0%−8.3
Q3 FY2023Sep 30, 20235.1%−7.9
Q2 FY2023Jun 30, 20231.1%−10.2
Q1 FY2023Mar 31, 20236.4%−2.4
Q4 FY2022Dec 31, 202213.3%+2.1
Q3 FY2022Sep 30, 202213.0%+1.8
Q2 FY2022Jun 30, 202211.3%+2.3
Q1 FY2022Mar 31, 20228.7%−3.9
Q4 FY2021Dec 31, 202111.2%−12.7
Q3 FY2021Sep 30, 202111.2%+2.4
Q2 FY2021Jun 30, 20219.0%+9.1
Q1 FY2021Mar 31, 202112.6%+10.0
Q4 FY2020Dec 31, 202023.9%+20.0
Q3 FY2020Sep 30, 20208.7%+16.0
Q2 FY2020Jun 30, 2020-0.1%−7.9
Q1 FY2020Mar 31, 20202.6%−6.5
Q4 FY2019Dec 31, 20193.9%−2.7
Q3 FY2019Sep 30, 2019-7.3%−10.9
Q2 FY2019Jun 30, 20197.8%+4.6
Q1 FY2019Mar 31, 20199.1%+6.0
Q4 FY2018Dec 31, 20186.6%−5.5
Q3 FY2018Sep 30, 20183.6%+2.5
Q2 FY2018Jun 30, 20183.1%−0.7
Q1 FY2018Mar 31, 20183.1%+0.6
Q4 FY2017Dec 31, 201712.0%+1.0
Q3 FY2017Sep 30, 20171.1%–
Q2 FY2017Jun 30, 20173.8%–
Q1 FY2017Mar 31, 20172.5%–
Q4 FY2016Dec 31, 201611.0%–

More Integra LifeSciences figures

See a number that looks wrong?